IRCT201410275283N11CompletedPhase 2
Comparison of metformin-megestrol combination and megestrol alone on endometrial histology in patients with disordered proliferative or hyperplastic endometrium.
Vice chancellor for Research,Tabriz University Of Medical Sciences0 sites84 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 84
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- Female
Inclusion Criteria
- •Patients with abnormal uterine bleeding and havingdisordered proliferative or hyperplastic endometrium with or without atypia; Consent to participate.
- •Exclusion criteria: Patients who have allergy to metformin; Patients with renal failure; nausea, vomiting, anorexia; anemia; cutaneous lesionsor not satisfied to participate in the study.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Phase 4
Treatment of endometrial hyperplasiaCondition 1: Other noninflammatory disorders of uterus, except cervix. Condition 2: Endometrial glandular hyperplasia. Condition 3: Endometrial adenomatous hyperplasia.Other noninflammatory disorders of uterus, except cervixEndometrial glandular hyperplasiaEndometrial adenomatous hyperplasiaIRCT201506252624N18Vice chancellor for research ,Iran University of Medical Sciences.36
Completed
Phase 2
Comparing the effect of Metformin and Megestrol acetate on endometrial histology in patients with disordered proliferative or hyperplastic endometrium. A RCTPatients with abnormal uterine bleeding and have disordered proliferative or hyperplastic endometrium with or without atypia.Endometrial glandular hyperplasiaIRCT201205265283N4Women's Reproductive Health Research Center, Tabriz University of Medical Sciences90
Completed
Phase 3
Evaluating the effect of Megestrol and metformin on women with endometrial hyperplasiaIRCT20140820018866N6Tehran University of Medical Sciences60
Suspended
Phase 1
A Randomised Double-Blind Controlled Trial of Metformin and Atorvastatin – with treatment commenced following prostatic biopsy and ceasing just before radical prostatectomy - to guide subsequent patient managementCancer - ProstateProstate cancerACTRN12615000571572niversity of Queensland Centre for Clinical Research80
Recruiting
Phase 3
empagliflozin effect in polycystic ovarian syndromPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20220822055771N1Shahre-kord University of Medical Sciences50